Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Malaria Vaccines
Studies from M.E. Patarroyo et al have provided new data on malaria vaccines
January 28th, 2009
Fresh data on malaria are presented in the report 'Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.' "An anti-malarial vaccine against the extremely lethal Plasmodium falciparum is desperately needed. Peptides from this parasite's proteins involved in invasion and having high red blood cell-binding ability were identified; these conserved peptides were not immunogenic or protection-inducing when used for immunizing Aotus monkeys," scientists writing in the Journal of Cellular and Molecular Medicine report. "Modifying some critical binding residues in these high-activiy binding peptides' (HABPs')...
Source: Vaccine Weekly (2009-01-28)
|
